Showing 2961-2970 of 23149 results for "".
Educational Accommodations for the ADHD Patient
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/educational-accommodations-for-the-adhd-patient/4095/How can educational accommodations be tailored to best fit ADHD patients? What role does an appropriate psychometric assessment of an ADHD patient play in determining the best educational accommodations for that patient? Do all institutions require similar documentation? Dr. Matthew Tominey, directoMultiple Myeloma: Current Treatment Modalities
https://reachmd.com/programs/clinicians-roundtable/multiple-myeloma-current-treatment-modalities/3008/Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients.Why Is Psoriatic Arthritis Often Misdiagnosed?
https://reachmd.com/programs/beyond-skin-deep/why-is-psoriatic-arthritis-often-misdiagnosed/10141/Gout or psoriatic arthritis? One patient's distressing experience on the road to diagnosis may have you thinking twice about the possibility of PsA.Breakthroughs in Generalized Pustular Psoriasis Treatment: Exploring Current & Emerging Approaches
https://reachmd.com/programs/clinicians-roundtable/breakthroughs-in-generalized-pustular-psoriasis-treatment-exploring-current-emerging-approaches/15833/Generalized pustular psoriasis is a variant of psoriasis that, if left untreated, could become fatal. How might emerging therapies help?Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
https://reachmd.com/programs/project-oncology/antibody-drug-conjugates-an-emerging-approach-in-nsclc-treatment/16363/What role might antibody-drug conjugates have on the therapeutic approach to NSCLC? Find out.Why Clinical Skills are Crucial to Early Psoriatic Arthritis Diagnosis
https://reachmd.com/programs/beyond-skin-deep/why-clinical-skills-are-crucial-to-early-psoriatic-arthritis-diagnosis/10147/Detecting PsA isn’t easy, but these essential tips will help sharpen your screening skills so you can make an accurate AND timely diagnosis.Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
https://reachmd.com/programs/Audioabstracts/vedolizumab-induction-and-maintenance-therapy-crohns-disease-patients-naive-or-who-have-failed-tumor/9537/Vedolizumab had increased efficacy over placebo in CD patients irrespective of TNF-α antagonist treatment history.Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
https://reachmd.com/programs/neurofrontiers/program-name/36356/Multiple sclerosis (MS) treatment has transformed dramatically, with a wide range of high-efficacy options currently available. Dr. Marisa McGinley, a neurologist at the Cleveland Clinic, explores how advancements in drug availability, administration methods, and efficacy are reshaping care, with aCan AI Transform How We Diagnose ATTR-CM?
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/can-ai-transform-how-we-diagnose-attr-cm/49039/Artificial intelligence (AI) is reshaping how clinicians identify transthyretin amyloid cardiomyopathy (ATTR-CM), offering new opportunities to improve early recognition and diagnostic accuracy. Joining Ryan Quigley to discuss the evolving non-biopsy diagnostic pathway and the growing role of AI inSERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
https://reachmd.com/programs/project-oncology/serena-6-assessing-camizestrants-impact-in-hrher2-breast-cancer/36163/The SERENA-6 trial, which was presented at the 2025 ESMO Congress, explores a novel strategy in treating HR+/HER2- advanced breast cancer by switching to camizestrant upon detection of ESR1 mutation prior to disease progression. This approach has been shown to improve progression-free survival and d